Drugs for Neglected Diseases
Drugs for Neglected Diseases
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stop Transmission of Gambiense Human African Trypanosomiasis | Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis | Recruiting | Phase 3 | 2026-08-27 | NCT07789743 | |
| A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). | Localized Cutaneous Leishmaniasis | Not yet recruiting | Phase 2 | 2026-05-05 | NCT06997159 | |
| Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT) | human African trypanosomiasis | Not yet recruiting | Phase 3 | 2024-04-10 | NCT06356974 | |
| Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease | Chagas disease, Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis, vector-borne disease | Recruiting | Phase 3 | 2023-11-30 | NCT04897516 |